BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9373468)

  • 1. Seven year follow-up of age-related maculopathy in an elderly British population.
    Sparrow JM; Dickinson AJ; Duke AM; Thompson JR; Gibson JM; Rosenthal AR
    Eye (Lond); 1997; 11 ( Pt 3)():315-24. PubMed ID: 9373468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of age-related maculopathy at two points in time in an elderly British population.
    Dickinson AJ; Sparrow JM; Duke AM; Thompson JR; Gibson JM; Rosenthal AR
    Eye (Lond); 1997; 11 ( Pt 3)():301-14. PubMed ID: 9373467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
    Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
    Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study.
    Buch H; Nielsen NV; Vinding T; Jensen GB; Prause JU; la Cour M
    Ophthalmology; 2005 May; 112(5):787-98. PubMed ID: 15878058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.
    Wang JJ; Rochtchina E; Lee AJ; Chia EM; Smith W; Cumming RG; Mitchell P
    Ophthalmology; 2007 Jan; 114(1):92-8. PubMed ID: 17198852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration.
    Sunness JS; Gonzalez-Baron J; Applegate CA; Bressler NM; Tian Y; Hawkins B; Barron Y; Bergman A
    Ophthalmology; 1999 Sep; 106(9):1768-79. PubMed ID: 10485549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort.
    Wang JJ; Foran S; Smith W; Mitchell P
    Arch Ophthalmol; 2003 May; 121(5):658-63. PubMed ID: 12742843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study.
    Jonasson F; Arnarsson A; Peto T; Sasaki H; Sasaki K; Bird AC
    Ophthalmology; 2005 Jan; 112(1):132-8. PubMed ID: 15629833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
    Tan JS; Mitchell P; Smith W; Wang JJ
    Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vitrectomy on age-related macular degeneration.
    Roller AB; Mahajan VB; Boldt HC; Abramoff MD; Russell SR; Folk JC
    Ophthalmology; 2010 Jul; 117(7):1381-6. PubMed ID: 20176401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year incidence of age-related maculopathy: the Visual Impairment Project.
    Mukesh BN; Dimitrov PN; Leikin S; Wang JJ; Mitchell P; McCarty CA; Taylor HR
    Ophthalmology; 2004 Jun; 111(6):1176-82. PubMed ID: 15177968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study.
    Bressler NM; Munoz B; Maguire MG; Vitale SE; Schein OD; Taylor HR; West SK
    Arch Ophthalmol; 1995 Mar; 113(3):301-8. PubMed ID: 7534060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration.
    Zweifel SA; Imamura Y; Spaide TC; Fujiwara T; Spaide RF
    Ophthalmology; 2010 Sep; 117(9):1775-81. PubMed ID: 20472293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.
    Klein R; Klein BE; Tomany SC; Meuer SM; Huang GH
    Ophthalmology; 2002 Oct; 109(10):1767-79. PubMed ID: 12359593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity.
    Klein R; Wang Q; Klein BE; Moss SE; Meuer SM
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):182-91. PubMed ID: 7822146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for second eye progression to advanced age-related macular degeneration: SST report No. 21 Submacular Surgery Trials Research Group.
    ; Solomon SD; Jefferys JL; Hawkins BS; Bressler NM; Bressler SB
    Retina; 2009 Sep; 29(8):1080-90. PubMed ID: 19734762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Macular drusen. Changes in the retinal pigment epithelium and angiographic characteristics as prognostic markers].
    Holz FG; Wolfensberger TJ; Piguet B; Minassian D; Bird AC
    Ophthalmologe; 1994 Dec; 91(6):735-40. PubMed ID: 7849424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas.
    Dentchev T; Milam AH; Lee VM; Trojanowski JQ; Dunaief JL
    Mol Vis; 2003 May; 9():184-90. PubMed ID: 12764254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Alabama Age-Related Macular Degeneration Grading System for donor eyes.
    Curcio CA; Medeiros NE; Millican CL
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1085-96. PubMed ID: 9620067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
    Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
    Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.